Melinta Therapeutics to Host Meetings at the Morgan Stanley 16th Annual Global Healthcare Conference

NEW HAVEN, Conn., Sept. 06, 2018 – Melinta Therapeutics, Inc. (NASDAQ: MLNT), a commercial-stage company discovering, developing and commercializing novel antibiotics to treat serious bacterial infections, today announced that the company will be attending and hosting meetings at the Morgan Stanley 16th Annual Global Healthcare Conference.